These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 472712)

  • 1. Müllerian duct regression in the embryo correlated with cytotoxic activity against human ovarian cancer.
    Donahoe PK; Swann DA; Hayashi A; Sullivan MD
    Science; 1979 Aug; 205(4409):913-5. PubMed ID: 472712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Source of the anti-Müllerian hormone synthesized by the fetal testis: Müllerian-inhibiting activity of fetal bovine Sertoli cells in tissue culture.
    Blanchard MG; Josso N
    Pediatr Res; 1974 Dec; 8(12):968-71. PubMed ID: 4444868
    [No Abstract]   [Full Text] [Related]  

  • 3. Mullerian inhibiting substance in human testes after birth.
    Donahoe PK; Ito Y; Morikawa Y; Hendren WH
    J Pediatr Surg; 1977 Jun; 12(3):323-30. PubMed ID: 17665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-Müllerian hormone.
    Josso N; Picard JY; Tran D
    Birth Defects Orig Artic Ser; 1977; 13(2):59-84. PubMed ID: 617047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the Müllerian-inhibiting activity of the human testis. Effect of fetal, peri-natal and post-natal human testicular tissue on the Müllerian duct of the fetal rat in organ culture.
    Josso N
    Biol Neonate; 1972; 20(5):368-79. PubMed ID: 4674819
    [No Abstract]   [Full Text] [Related]  

  • 6. Pretreatment of chick embryos with estrogen in ovo prevents mullerian duct regression in organ culture.
    Doi O; Hutson JM
    Endocrinology; 1988 Jun; 122(6):2888-91. PubMed ID: 3371264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decrease in the secretion of anti-Müllerian hormone by the chick testis during development].
    Maraud R; Vergnaud O
    C R Seances Soc Biol Fil; 1986; 180(5):521-4. PubMed ID: 2950974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone of mullerian regression, inducing agent of the testis in chick embryo].
    Stoll R; Rashedi M; Maraud R
    Bull Assoc Anat (Nancy); 1978 Mar; 62(176):131-43. PubMed ID: 569519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular localization of müllerian inhibiting substance in the developing rat ovary.
    Ueno S; Takahashi M; Manganaro TF; Ragin RC; Donahoe PK
    Endocrinology; 1989 Feb; 124(2):1000-6. PubMed ID: 2643506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preservation of Mullerian inhibiting substance during long-term freezing of testicular fragments.
    Donahoe PK; Ito Y; Hendren WH
    Cryobiology; 1977 Oct; 14(5):534-42. PubMed ID: 561675
    [No Abstract]   [Full Text] [Related]  

  • 11. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The secretion of Mullerian inhibiting substance by cultured isolated Sertoli cells of the neonatal calf.
    Price JM
    Am J Anat; 1979 Sep; 156(1):147-57. PubMed ID: 517448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of the testosterone treated chicken testis on the regression of the Müllerian duct].
    Maraud R; Vergnaud O; Stoll R
    C R Seances Soc Biol Fil; 1978; 172(3):446-9. PubMed ID: 153170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical period for mullerian duct regression in the dog embryo.
    Meyers-Wallen VN; Manganaro TF; Kuroda T; Concannon PW; MacLaughlin DT; Donahoe PK
    Biol Reprod; 1991 Oct; 45(4):626-33. PubMed ID: 1751638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on Mullerian-inhibiting substance: its potential application against ovarian cancer.
    Wong RR; Worley MJ; Chung TK; Wong YF
    Endocr Relat Cancer; 2014 Jun; 21(3):R227-33. PubMed ID: 24623744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
    Pieretti-Vanmarcke R; Donahoe PK; Szotek P; Manganaro T; Lorenzen MK; Lorenzen J; Connolly DC; Halpern EF; MacLaughlin DT
    Clin Cancer Res; 2006 Mar; 12(5):1593-8. PubMed ID: 16533786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
    MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
    Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of Bmpr1a for Müllerian duct regression during male sexual development.
    Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
    Nat Genet; 2002 Nov; 32(3):408-10. PubMed ID: 12368913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.
    Gustafson ML; Lee MM; Scully RE; Moncure AC; Hirakawa T; Goodman A; Muntz HG; Donahoe PK; MacLaughlin DT; Fuller AF
    N Engl J Med; 1992 Feb; 326(7):466-71. PubMed ID: 1732773
    [No Abstract]   [Full Text] [Related]  

  • 20. Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line.
    Fuller AF; Guy S; Budzik GP; Donahoe PK
    J Clin Endocrinol Metab; 1982 May; 54(5):1051-5. PubMed ID: 6895900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.